Anxiety levels in patients admitted to the emergency department with myocardial infarction or COVID-19 pneumonia
| dc.authorid | 0000-0002-0161-1167 | |
| dc.authorid | 0000-0002-9653-7958 | |
| dc.contributor.author | Çağlar, Ahmet | |
| dc.contributor.author | Kaçer, İlker | |
| dc.date.accessioned | 2021-05-26T07:27:26Z | |
| dc.date.available | 2021-05-26T07:27:26Z | |
| dc.date.issued | 2022 | |
| dc.department | Tıp Fakültesi | |
| dc.description | *Çağlar, Ahmet ( Aksaray, Yazar ) | |
| dc.description.abstract | The COVID-19 related high morbidity and mortality have led to a common fear and anxiety. This study aimed to determine the state/trait and death anxiety levels of patients with myocardial infarction (MI) and COVID-19 pneumonia. The study was conducted at the emergency department of a tertiary hospital in Central Anatolia of Turkey. 120 patients with myocardial infarction , 120 patients with COVID-19 pneumonia, and 120 healthy volunteers as a control group were included in the study. The participants filled out the questionnaire that included the State-Trait Anxiety Inventory (STAI) and the Thorson-Powell's Revised Death Anxiety Scale (RDAS). All scores of patient groups were significantly higher than the control group. There was no significant difference in terms of STAI-S, STAI-T, and RDAS scores between COVID-19 pneumonia and MI groups. The anxiety risk increased 2.14-fold for STAI-T and 1.97-fold for STAI-S in patients with COVID-19 pneumonia compared to the control group. In this study, the state/trait and death anxiety levels of patients with COVID-19 pneumonia were as high as patients with myocardial infarction.COVID-19 pneumonia-related anxiety was associated with chronic diseases and smoking. Knowing the level of anxiety in these patients is important to provide better health services in the emergency departments. | |
| dc.identifier.doi | 10.1080/13548506.2021.1876893 | |
| dc.identifier.endpage | - | en_US |
| dc.identifier.issue | - | en_US |
| dc.identifier.pmid | 33486994 | |
| dc.identifier.scopusquality | N/A | |
| dc.identifier.startpage | - | en_US |
| dc.identifier.uri | https:/dx.doi.org/10.1080/13548506.2021.1876893 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12451/7973 | |
| dc.identifier.volume | - | en_US |
| dc.identifier.wos | WOS:000611945000001 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Taylor & Francis | |
| dc.relation.ispartof | Psychology, Health & Medicine | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | COVID-19 | |
| dc.subject | Myocardial Infarction | |
| dc.subject | Emergency Department | |
| dc.subject | State-Trait Anxiety Inventory | |
| dc.subject | Thorson-Powell's Revised Death Anxiety Scale | |
| dc.title | Anxiety levels in patients admitted to the emergency department with myocardial infarction or COVID-19 pneumonia | |
| dc.type | Article |
